Posts by Team VIVA!
What does the King Review mean for Pharmacy in Australia – August 5, 2016
Following the release of a discussion paper dubbed the “King Review” (as the Productivity Commission’s, Stephen King headed the review panel), which has been developed to review pharmacy remuneration and regulation procedures, discussions have opened up this week around what the review recommends and how this can impact pharmacy. The Federal Government and the Pharmacy…
Read MoreBREAKING NEWS: Chemmart & Terry White Merger anticipated end of October – August 4, 2016
This morning (August 4, 2016), EBOS Group Limited announced plans to merge its Chemmart business with the Terry White Group businesses, in order to create one of Australia’s largest retail pharmacy groups. In an EBOS investor release published today (August 4, 2016), the wholesaler announced the merge of Chemmart with Terry White would equate to…
Read MoreAustralia’s only locally manufactured QIV now TGA approved – August 2, 2016
Australia’s only locally manufactured, quadrivalent seasonal influenza vaccine (QIV) received Therapeutic Goods Administration (TGA) approval on July 15, 2016. Afluria Quad™, Seqirus’ four-strain, inactivated seasonal influenza vaccine, is indicated for people aged 18 years and older.1 The new quadrivalent vaccine will replace the company’s trivalent vaccine (TIV), Fluvax® for the 2017 flu season. Manufactured by…
Read MoreVIVA! Communications & GLOBALHealthPR pledge their support for World Hepatitis Day – July 28, 2016
VIVA! Communications and GLOBALHealthPR are proud to announce their official support for World Hepatitis Day, July 28, 2016, joining a plethora of organisations that are fighting to ELIMINATE chronic Hepatitis C. World Hepatitis Day unites people from all walks of life to raise awareness of the substantial global burden of viral hepatitis and to provoke…
Read MoreResearchers develop vaccine targeting abnormal proteins that trigger Alzheimer’s – July 16, 2016
A vaccine to prevent the onset of Alzheimer’s disease is a step closer following a breakthrough development that successfully targets the abnormal proteins that trigger the disease. In what is being hailed as the first vaccine of its kind, Flinders University, Adelaide and US researchers contend the vaccine could be used to prevent Alzheimer’s, and…
Read More